New Treatment Method Safe, Effective for Advanced Melanoma Patients, Pitt Researchers Find
CHICAGO, June 5 – Patients undergoing treatment for melanoma that has spread to the liver may respond well to chemotherapy delivered directly into the liver’s blood vessels, according to a study sponsored by the National Cancer Institute and Delcath Systems Inc., and led by James F. Pingpank, M.D., associate professor of surgery, University of Pittsburgh School of Medicine, and surgical oncologist with UPMC Cancer Centers . The results will be disclosed in an oral presentation on June 5 in Chicago at the 46th annual